智通财经APP获悉，医渡科技(02158)现涨超6%，截至发稿，涨6.06%，报5.78港元，成交额5247.18万港元。
消息面上，近期，医渡科技官微发布3月动态。在科研领域，公司积极投身国家重点研发计划“前沿生物技术”专项，为慢病防治提供创新方案。行业交流层面，频繁亮相于北京卫视《专精特新研究院》、中关村论坛年会等重要平台，深度探讨AI医疗发展，分享数智科技成果。业务拓展方面，医渡科技成功打造首个肝癌专科“AI医生”，并与多地医院开展深度合作，推进大模型智能导诊、数字疗法等应用。其“科研门诊”正式开诊，中标多个医院、企业项目，彰显卓越市场竞争力。此外，医渡科技六度蝉联医疗大数据企业榜首，获得多家机构研报推荐，进一步巩固行业领先地位。
国金证券指出，医渡科技是AI+医疗领域头部公司，自成立起即合作顶尖医院进行医学科研数据治理，相关经验积累形成YiduCore核心AI算法，客户逐步拓展至药企、卫健委和医保端。据悉，截至目前，医渡科技已经深度参与北京、深圳等4省12市“惠民保”项目的开发和运营，累计服务参保用户超3400万人次。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.